Table 2.
Convalescent Plasma Group (n = 59) | Control Group (n = 59) | p-Value 1 | |
---|---|---|---|
Status at day 14 | n (%) | n (%) | 0.249 |
Discharged | 21 (35.6) | 31 (52.5) | |
Hospitalized | 30 (50.8) | 18 (30.5) | |
In ICU | 8 (13.6) | 5 (8.5) | |
Death | 0 (0.0) | 5 (8.5) | |
Status at day 28 | n (%) | n (%) | 0.566 |
Discharged | 48 (81.4) | 46 (78.0) | |
Hospitalized | 5 (8.5) | 5 (8.5) | |
In ICU | 5 (8.5) | 3 (5.1) | |
Death | 1 (1.7) | 5 (8.5) | |
Status at end of follow-up | n (%) | n (%) | 0.106 |
Discharged | 56 (94.9 | 51 (86.4) | |
Hospitalized | 0 (0.0) | 0 (0.0) | |
In ICU | 1 (1.7) | 0 (0.0) | |
Death | 2 (3.4) | 8 (13.6) | |
Follow-up, median (IQR) | 29 (24) | 10 (11) | <0.001 |
Duration of hospital stay, median (IQR) | 15 (10) | 10 (11) | 0.006 |
Admission to ICU, n (%) | 16 (27.1) | 9 (15.3) | 0.116 |
Exit from ICU, n (%) | 13 (22.0) | 2 (3.4) | 0.014 |
Time to exit from ICU, median (IQR) | 12.5 (37.25) | 7 (NC) | 0.824 |
Intubation, n (%) | 16 (27.1) | 8 (13.6) | 0.068 |
Extubation, n (%) | 13 (22.0) | 1 (1.7) | 0.006 |
Time to extubation, median (IQR) | 15 (35.5) | 17.5 (NC) | 0.837 |
Duration of oxygen support, median (IQR) | 7 (11.5) | NA | |
Achievement of negative PCR, n (%) | 37 (62.7) | 19 (52.8) | 0.167 |
Time to PCR negativity, median (IQR) | 14 (14) | 9.5 (14.8) | 0.007 |
1 Highlighted (bold) p-values denote statistically significant results.